Hematology

Risk and Outcome of Second primary malignancy in patients with classical Hodgkin lymphoma
Fan Wang

medRxiv 2022.08.06.22278488; doi: https://doi.org/10.1101/2022.08.06.22278488

Add to Selected Citations
Combination Venetoclax and Selinexor Effective in Relapsed Refractory Multiple Myeloma with Translocation t(11;14)
Nina Nguyen, Sana Chaudhry, Tulasigeri M. Totiger, Robert Diaz, Evan Roberts, Skye Montoya, Gabriel Pardo, Alejandro Pardo, Jumana Afaghani, Maurizio Affer, Jacob Jahn, Terrence Bradley, Francesco Maura, Dickran Kazandjian, Daniel Bilbao, Jennifer Chapman, Ola Landgren, James Hoffman, Justin Taylor

medRxiv 2022.08.01.22278282; doi: https://doi.org/10.1101/2022.08.01.22278282

Add to Selected Citations
The transcriptomic landscape of normal and ineffective erythropoiesis at single cell resolution
Raymond T. Doty, Christopher G. Lausted, Adam D. Munday, Zhantao Yang, Xiaowei Yan, Changting Meng, Qiang Tian, Janis L. Abkowitz

medRxiv 2022.08.01.22278133; doi: https://doi.org/10.1101/2022.08.01.22278133

Add to Selected Citations
Frequent whole blood donations select for DNMT3A variants mediating enhanced response to erythropoietin
D. Karpova, H. Huerga Encabo, E. Donato, I. Kotova, S. Calderazzo, AM. Leppä, J. Panten, A. Przbylla, E. Seifried, A. Kopp-Schneider, TN. Wong, D. Bonnet, H. Bonig, A. Trumpp

medRxiv 2022.07.24.22277825; doi: https://doi.org/10.1101/2022.07.24.22277825

Add to Selected Citations
Modelling of immune response in chronic myeloid leukemia patients suggests potential for treatment reduction prior to cessation
Elena Karg, Christoph Baldow, Thomas Zerjatke, Richard E Clark, Ingo Roeder, Artur C. Fassoni, Ingmar Glauche

medRxiv 2022.06.28.22277004; doi: https://doi.org/10.1101/2022.06.28.22277004

Add to Selected Citations
First Point-of-Care Diagnostic Test for Beta-Thalassemia
Ran An, Alireza Avanaki, Priyaleela Thota, Sai Nemade, Amrish Mehta, Umut A. Gurkan

medRxiv 2022.06.20.22276414; doi: https://doi.org/10.1101/2022.06.20.22276414

Add to Selected Citations
Real-world treatment patterns and clinical outcomes in Korean patients with AML ineligible for first-line intensive chemotherapy: A subanalysis of the CURRENT study, a non-interventional, retrospective chart review
Soo-Mee Bang, Ka-Won Kang, Ik-Chan Song, Alexander Delgado, Cynthia Llamas, Yinghui Duan, Ji-Young Jeong, Je-Hwan Lee

medRxiv 2022.06.15.22276442; doi: https://doi.org/10.1101/2022.06.15.22276442

Add to Selected Citations
A simple, cost-effective and extraction-free molecular diagnostic test for sickle cell disease in noninvasive buccal swab specimen for a limited-resource setting
Priya Thakur, Pragya Gupta, Nupur Bhargava, Rajat Soni, Narendra Verma, Sangam Giri Goswami, Gaurav Kharya, Vinodh Saravanakumar, Padma G, Suman Jain, Jasmita Dass, Mukul Aggarwal, Sivaprakash Ramalingam

medRxiv 2022.06.14.22276141; doi: https://doi.org/10.1101/2022.06.14.22276141

Add to Selected Citations
Rapid detection of myeloid neoplasm fusions using Single Molecule Long-Read Sequencing
Olga Sala-Torra, Shishir Reddy, Ling-Hong Hung, Lan Beppu, David Wu, Jerald Radich, Ka Yee Yeung, Cecilia CS Yeung

medRxiv 2022.06.16.22276469; doi: https://doi.org/10.1101/2022.06.16.22276469

Add to Selected Citations
Baseline Peripheral Blood Counts and Outcomes in Patients Presenting with COVID-19
Preethi Jeyaraman, Pronamee Borah, Omender Singh, Arun Dewan, Nitin Dayal, Rahul Naithani

medRxiv 2022.06.10.22276256; doi: https://doi.org/10.1101/2022.06.10.22276256

Add to Selected Citations

Hematology

Pages